Get complete information related to latest Stent Tenders . from India at Classic Tenders. Search the best available tenders from Indian government tenders, domestic Stent Tenders , private tenders, online tenders, tender invitation notice, business tender notices, online tenders and bidding Stent Tenders.
Tender For supply of 3 way extension -triple lumen with three bionectors and clamps for peripheral or central venous use. to connect to the catheter several independent iv lines octopus prototype , l j medium slants , christensens urease agar base 500 gms , urea 40 percent 1 vial per 95 ml , complement c3 kits , complement c4 kits , broth microdilution kit for colistin resistance , formalin tablets -100 x 1gm tablets approximately for vapour sterilization , kidney stone analysis kit- 50 tests , double j stent 4 fg 16 cm one end open.use 0.018 guidewire , double j stent 4.5 fg 26 cm. one end closed .use 0.028 guidewire , double j stent 5 fg 26 cm . one end closed .use 0.035 guidewire , double j stent 6 fg 26 cm. one end closed .use 0.038 guidewire , pcn malecot catheter 16fr 30 cm. use 0.038 guidewire , ureteric catheter 4fg 70 cm.open end. use 0.025 guidewire , ureteric catheter 5fg 70 cm.open end.use 0.035 guidewire , uti chrome agar 500gms , pelvic binders large , pelvic binders medium , pelvic binders small
Tender For srph153047-coronary drug eluting stents with (1) cobalt chromium alloy (2)coating of bioabsorbable polymer carrier with abluminal and gradient coating for active drug shown to be effective in preventing neo-intimal hyperplasia) (3) stent diameter should be from 2.5mm to 4mm . the length of the stent should be from 12mm to 38 mm. (4) the strut thickness should be 91 micron or less. (5) stent delivery system shouldbe monorail (single operator exchange or rapid exchange). (6) stent should be compatible with 5fr guiding catheter (7) stent design should be open cell type. (8) stent should be approved by dcgi. the copy of dcgi approval should be enclosed in the tenderbid. (9) the long term efficacy and safety of the stent, the rates of in-stent restenosis (isr) and in-situ thrombosis (ist) should be documented / published in peer reviewed scientific journals. (10) safety of abbreviated (one month) dual antiplatelet therapy for high bleeding risk patients should be documented in peer reviewed journals. (11) themanufacturer/supplier should submit proof of supply of the stent to a major government institute. bis standards for the drug eluting stent are not available. (reference:bis catalogue ). unit: no.
Tender For supply of everolimus oblique zotarolimus drug eluting cobalt chromium oblique platinum chromium coronary stent assorted sizes bis and equivalent , everolimus oblique zotarolimus eluting platinum oblique cobalt chromium 4th generation drug eluting coronary stent assorted sizes , drug eluting stent iii rd generation sirolimus eluting coronary stent system with biodegradable polymer and temperature control packing assorted sizes , drug eluting stents consists of cocr platform with bio inspired stent design bio degradable polymer bracket in pdlla pcl and serolimus drug with abluminal and gradient coating of durg , sirolimus eluting 4th generation stent assorted sizes , dual drug polymer free producol and sirolimus eluting stents microporous surface and shellac top coat assorted sizes , non compliant coronary ballon bracket in 2 point 75 into mm assorted sizes , non compliant coronary balloon bracket in 3 point 0 mm assorted size , non compliant coronary balloon bracket in 3 point 5 mm assorted size , non compliant coronary bracket in 2 point 25 mm assorted sizes bis and equivalent , non compliant coronary bracket in2 point 5 mm assorted sizes bis and equivalent , paclitaxel drug eluting coronary balloon dilation catheter assorted sizes bis and equivalent , sirolimus coated drug eluting balloon with nano lute technology and phsopholipd carrier bracket inassorted size , non compliant coronary balloon bracket in4 point 0xmm assorted sizes bis and equivalent , semi compliant ptca balloon bracket in 2 point 0mm assorted size , semi compliant ptca balloon bracket in2 point 25 mm assorted sizes bis and equivalent , semi compliant ptca balloon bracket in 2 point 5mm assorted size , semi compliant rapid exchange dilation catheter with ultra terumo low profile for better cross ability in cto andcomlex cases 0 point 40 mm
Tender For supply of instruments for paediatric ophthalmology and orthoptic evaluation - accomodative flippers for adult, allen cards, clip on trial lens holder, fixation stick for adult and children, handheld autorefractometer & keratometer, lea symbol chart, log mar chart, log mar illiterate e chart, maddox wing, mem fixation card for near retinoscopy, mohindra retinoscopy lens series, muscle imbalance card/phoria card for near and distance, okn drum, paediatric accomodation procedure kit (covd kit), paediatric trial frame, pelli robson contrast sensitivity, prism bar and cover test set, randot preschool test card, stereo test card with polaroid glass, synoptophore, vision therapy kit, worth 4-dot torch (near), binocular indirect opthalmoscope with led illumination (high end), alfonso baby eye speculum, accentrix (ranibizumab) pfs
Tender For srph153049-coronary drug eluting stents (1) single wire technology on c obalt based alloy platform (2) stent with coating of biolinx polymer carrier for ac tive drug zotarolimus shown to be effective in preventing neo-intimal hyperplasia) (3) stent diameter should be from 2.25 mm to 4 mm and length of the stent from 12mm to 38 mm. (4) the strut thickness should be 81 micron or less. (5) stent delivery syste m should be monorail (single operator exchange or rapid exchange). (6) stent shou ld be compatible with 5fr guiding catheter (7) stent design should be open cell type . (8) stent should be approved by dcgi. the copy of dcgi approval should be enclose d in the tender bid. (9) five years long term efficacy and safety of the stent in term s of target vessel revascularisation (tvr) and in-situ thrombosis (ist) should be do cumented / published in peer reviewed scientific journals.(10) the documents pertai ning to the efficacy and safety of the stent should be enclosed for the brand that is offered in the tender bid (11) the manufacturer/supplier should submit proof of supply of the stent to a major government institute. unit:no
Tender For srph153048-des-abbreviated dapt long -coronary drug eluting stents wit h (1) platinum chromium alloy (2) coating of bioabsorbable polymer carrier for acti ve drug everolimus shown to be effective in preventing neo-intimal hyperplasia) (3) stent diameter should be from 2.5mm to 4mm. the length of the stent should be fro m 12mm to 48 mm. (4) the strut thickness should be 91 micron or less. (5) stent deliver y system should be monorail (single operator exchange or rapid exchange). (6) ste nt should be compatible with 5fr guiding catheter (7) stent design should be open c ell type. (8) stent should be approved by dcgi. the copy of dcgi approval should be enclosed in the tender bid. (9) the long term efficacy and safety of the stent, the r ates of in-stent restenosis (isr) and in-situ thrombosis (ist) should be documented / published in peer reviewed scientific journals. (10) safety of abbreviated (three mo nth) dual antiplatelet therapy for high bleeding risk patients should be document ed in peer reviewed journals. (11) the manufacturer/supplier should submit proof o f supply of the stent to a major government institute. bis standards for the drug eluting stent are not available. (reference:bis catalogue ). unit:no
Tender For srph153042-coronary drug eluting stents with (1) stent on cobalt chromi um alloy or platinum chromium alloy. (2) stent with coating of polymer carrier for active drug ( sirolimus, everolimus or zotarolimus shown to be effective in preven ting neo-intimal hyperplasia) (3) stent diameter should be from 2.5mm to 4mm . the le ngth of the stent should be 12 to 48mm . (4) the strut thickness should be 91 micron or less. (5) stent delivery system should be monorail (single operator exchange or rapid exchange). (6) stent should be compatible with 5fr guiding catheter (7) stent d esign should be open cell type. (8) stent should be approved by dcgi. the copy of dc gi approval should be enclosed in the tender bid / offer. (9) the long term efficacy and safety of the stent, the rates of in-stent restenosis (isr) and in-situ thrombosi s (ist) should be documented / published in peer reviewed scientific journals. (10)the manufacturer/supplier should submit proof of supply of the stent to a major gov ernment institute.bis standards for the drug eluting stent are not available (refe rence : bis catalogue ) unit: no.